352 related articles for article (PubMed ID: 30973183)
1. Brain neurochemistry in unmedicated obsessive-compulsive disorder patients and effects of 12-week escitalopram treatment:
Parmar A; Sharan P; Khandelwal SK; Agarwal K; Sharma U; Jagannathan NR
Psychiatry Clin Neurosci; 2019 Jul; 73(7):386-393. PubMed ID: 30973183
[TBL] [Abstract][Full Text] [Related]
2. The right thalamic glutamate level correlates with functional connectivity with right dorsal anterior cingulate cortex/middle occipital gyrus in unmedicated obsessive-compulsive disorder: A combined fMRI and
Chen Y; Meng Z; Zhang Z; Zhu Y; Gao R; Cao X; Tan L; Wang Z; Zhang H; Li Y; Fan Q
Aust N Z J Psychiatry; 2019 Mar; 53(3):207-218. PubMed ID: 30354192
[TBL] [Abstract][Full Text] [Related]
3. Abnormalities in metabolite concentrations in tourette's disorder and obsessive-compulsive disorder-A proton magnetic resonance spectroscopy study.
Fan S; Cath DC; van den Heuvel OA; van der Werf YD; Schöls C; Veltman DJ; Pouwels PJW
Psychoneuroendocrinology; 2017 Mar; 77():211-217. PubMed ID: 28104554
[TBL] [Abstract][Full Text] [Related]
4. Anterior cingulate glutamate-glutamine levels predict symptom severity in women with obsessive-compulsive disorder.
Yücel M; Wood SJ; Wellard RM; Harrison BJ; Fornito A; Pujol J; Velakoulis D; Pantelis C
Aust N Z J Psychiatry; 2008 Jun; 42(6):467-77. PubMed ID: 18465373
[TBL] [Abstract][Full Text] [Related]
5. Proton magnetic resonance spectroscopy in obsessive-compulsive disorder: evidence for reduced neuronal integrity in the anterior cingulate.
Tükel R; Aydın K; Ertekin E; Özyıldırım SŞ; Taravari V
Psychiatry Res; 2014 Dec; 224(3):275-80. PubMed ID: 25241042
[TBL] [Abstract][Full Text] [Related]
6. Effects of intensive cognitive-behavioral therapy on cingulate neurochemistry in obsessive-compulsive disorder.
O'Neill J; Gorbis E; Feusner JD; Yip JC; Chang S; Maidment KM; Levitt JG; Salamon N; Ringman JM; Saxena S
J Psychiatr Res; 2013 Apr; 47(4):494-504. PubMed ID: 23290560
[TBL] [Abstract][Full Text] [Related]
7. Spectroscopic abnormalities in the pregenual anterior cingulate cortex in obsessive-compulsive disorder using proton magnetic resonance spectroscopy: a controlled study.
Kosová E; Pajuelo D; Fajnerová I; Greguš D; Brunovský M; Stopková P; Škoch A; Fürstová P; Španiel F; Horáček J
BMC Psychiatry; 2023 Oct; 23(1):734. PubMed ID: 37817131
[TBL] [Abstract][Full Text] [Related]
8. 1H magnetic resonance spectroscopy evidence for occipital involvement in treatment-naive paediatric obsessive-compulsive disorder.
Ljungberg M; Nilsson MKL; Melin K; Jönsson L; Carlsson A; Carlsson Å; Forssell-Aronsson E; Ivarsson T; Carlsson M; Starck G
Acta Neuropsychiatr; 2017 Jun; 29(3):179-190. PubMed ID: 27772535
[TBL] [Abstract][Full Text] [Related]
9. A 1H magnetic resonance spectroscopy study in adults with obsessive compulsive disorder: relationship between metabolite concentrations and symptom severity.
Starck G; Ljungberg M; Nilsson M; Jönsson L; Lundberg S; Ivarsson T; Ribbelin S; Ekholm S; Carlsson A; Forssell-Aronsson E; Carlsson ML
J Neural Transm (Vienna); 2008 Jul; 115(7):1051-62. PubMed ID: 18528631
[TBL] [Abstract][Full Text] [Related]
10. Anterior thalamic radiation structural and metabolic changes in obsessive-compulsive disorder: A combined DTI-MRS study.
Wang R; Fan Q; Zhang Z; Chen Y; Zhu Y; Li Y
Psychiatry Res Neuroimaging; 2018 Jul; 277():39-44. PubMed ID: 29807209
[TBL] [Abstract][Full Text] [Related]
11. Decreased thalamic glutamate level in unmedicated adult obsessive-compulsive disorder patients detected by proton magnetic resonance spectroscopy.
Zhu Y; Fan Q; Han X; Zhang H; Chen J; Wang Z; Zhang Z; Tan L; Xiao Z; Tong S; Maletic-Savatic M; Li Y
J Affect Disord; 2015 Jun; 178():193-200. PubMed ID: 25819113
[TBL] [Abstract][Full Text] [Related]
12. Investigation of anterior cingulate cortex gamma-aminobutyric acid and glutamate-glutamine levels in obsessive-compulsive disorder using magnetic resonance spectroscopy.
Li Y; Zhang CC; Kathrin Weidacker ; Zhang Y; He N; Jin H; Chen W; Voon V; Edden RAE; Yan F
BMC Psychiatry; 2019 May; 19(1):164. PubMed ID: 31146727
[TBL] [Abstract][Full Text] [Related]
13. In vivo effects of ketamine on glutamate-glutamine and gamma-aminobutyric acid in obsessive-compulsive disorder: Proof of concept.
Rodriguez CI; Kegeles LS; Levinson A; Ogden RT; Mao X; Milak MS; Vermes D; Xie S; Hunter L; Flood P; Moore H; Shungu DC; Simpson HB
Psychiatry Res; 2015 Aug; 233(2):141-7. PubMed ID: 26104826
[TBL] [Abstract][Full Text] [Related]
14. 1H-MRS of the anterior cingulate cortex in childhood and adolescent obsessive-compulsive disorder: a case-control study.
Ortiz AE; Ortiz AG; Falcon C; Morer A; Plana MT; Bargalló N; Lázaro L
Eur Neuropsychopharmacol; 2015 Jan; 25(1):60-8. PubMed ID: 25499604
[TBL] [Abstract][Full Text] [Related]
15. Decrease in caudate glutamatergic concentrations in pediatric obsessive-compulsive disorder patients taking paroxetine.
Rosenberg DR; MacMaster FP; Keshavan MS; Fitzgerald KD; Stewart CM; Moore GJ
J Am Acad Child Adolesc Psychiatry; 2000 Sep; 39(9):1096-103. PubMed ID: 10986805
[TBL] [Abstract][Full Text] [Related]
16. The relationship between oxidative stress markers and 1H-Magnetic resonance spectroscopy findings in obsessive compulsive disorder.
Subaşı Turgut F; Bulut M; Hattapoğlu S; Güneş M; Cemal Kaya M; Ekici F; Guli Çetinçakmak M; Kaplan İ; Atmaca M
Brain Res; 2024 Jun; 1833():148852. PubMed ID: 38494099
[TBL] [Abstract][Full Text] [Related]
17. Investigation of cortical glutamate-glutamine and γ-aminobutyric acid in obsessive-compulsive disorder by proton magnetic resonance spectroscopy.
Simpson HB; Shungu DC; Bender J; Mao X; Xu X; Slifstein M; Kegeles LS
Neuropsychopharmacology; 2012 Nov; 37(12):2684-92. PubMed ID: 22850733
[TBL] [Abstract][Full Text] [Related]
18. Cingulate and thalamic metabolites in obsessive-compulsive disorder.
O'Neill J; Lai TM; Sheen C; Salgari GC; Ly R; Armstrong C; Chang S; Levitt JG; Salamon N; Alger JR; Feusner JD
Psychiatry Res Neuroimaging; 2016 Aug; 254():34-40. PubMed ID: 27317876
[TBL] [Abstract][Full Text] [Related]
19. Altered serotonin transporter binding potential in patients with obsessive-compulsive disorder under escitalopram treatment: [11C]DASB PET study.
Kim E; Howes OD; Park JW; Kim SN; Shin SA; Kim BH; Turkheimer FE; Lee YS; Kwon JS
Psychol Med; 2016 Jan; 46(2):357-66. PubMed ID: 26423910
[TBL] [Abstract][Full Text] [Related]
20. A proton MRSI study of brain N-acetylaspartate level after 12 weeks of citalopram treatment in drug-naive patients with obsessive-compulsive disorder.
Jang JH; Kwon JS; Jang DP; Moon WJ; Lee JM; Ha TH; Chung EC; Kim IY; Kim SI
Am J Psychiatry; 2006 Jul; 163(7):1202-7. PubMed ID: 16816225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
